Richard Daniell
EVP, Europe Commercial · 4 filings · Latest: May 5, 2026
TEVA PHARMACEUTICAL INDUSTRIES LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEVA | Richard Daniell | EVP, Europe Commercial | May 5, 2026 | Sale | $35.40 | 30,000 | $1.1M | 55,755 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 5, 2026 | Sale | $31.67 | 17,295 | $547.7K | 85,755 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 5, 2026 | Option Exercise | — | 17,295 | — | 103,050 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 4, 2026 | Sale | $32.66 | 91,345 | $3.0M | 85,755 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 4, 2026 | Option Exercise | — | 53,973 | — | 143,588 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 3, 2026 | Sale | $32.36 | 128,985 | $4.2M | 123,127 | |
TEVA | Richard Daniell | EVP, Europe Commercial | Mar 3, 2026 | Option Exercise | — | 203,728 | — | 189,862 |